clonidine has been researched along with Atrophy in 3 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clonidine is a centrally active alpha 2-adrenoceptor agonist that raises concentrations of GH in serum in healthy people and those with pure autonomic failure (with peripheral lesions), but not in those with MSA (with a central autonomic deficit)." | 5.30 | Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. ( Kimber, JR; Mathias, CJ; Watson, L, 1997) |
| "Clonidine is a centrally active alpha 2-adrenoceptor agonist that raises concentrations of GH in serum in healthy people and those with pure autonomic failure (with peripheral lesions), but not in those with MSA (with a central autonomic deficit)." | 1.30 | Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. ( Kimber, JR; Mathias, CJ; Watson, L, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eden, J | 1 |
| Kimber, JR | 1 |
| Watson, L | 1 |
| Mathias, CJ | 1 |
| Clarke, CE | 1 |
| Ray, PS | 1 |
| Speller, JM | 1 |
1 review available for clonidine and Atrophy
| Article | Year |
|---|---|
ENDOCRINE DILEMMA: Managing menopausal symptoms after breast cancer.
Topics: Administration, Intravaginal; Administration, Topical; Atrophy; Bone Density Conservation Agents; Br | 2016 |
2 other studies available for clonidine and Atrophy
| Article | Year |
|---|---|
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
Topics: Adrenergic alpha-Agonists; Atrophy; Autonomic Nervous System Diseases; Clonidine; Diagnosis, Differe | 1997 |
Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Aged; Atrophy; Autonomic Nervous System Diseases; Clonidine; Diagnosis, D | 1999 |